Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation

Journal of Immunology - Tập 165 Số 6 - Trang 2950-2954 - 2000
Edward Abraham1, John J. Arcaroli1, Aaron B. Carmody1, Haichao Wang2, Kevin J. Tracey2
1*Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO 80262; and
2†Laboratory of Biomedical Science, North Shore University Hospital-New York University School of Medicine, Manhasset, NY 11030

Tóm tắt

Abstract Acute inflammatory lung injury is often a delayed complication of critical illness and is associated with increased mortality. High mobility group-1 (HMG-1) protein, in addition to its role as a transcriptional regulatory factor, has recently been identified as a late mediator of endotoxin lethality. In the present studies, HMG-1 given intratracheally produced acute inflammatory injury to the lungs, with neutrophil accumulation, the development of lung edema, and increased pulmonary production of IL-1β, TNF-α, and macrophage-inflammatory protein-2. In endotoxin-induced acute lung inflammation, administration of anti-HMG-1 Abs either before or after endotoxin exposure decreased the migration of neutrophils to the lungs as well as lung edema. These protective effects of anti-HMG-1 were specific, because pulmonary levels of IL-1β, TNF-α, or macrophage-inflammatory protein-2 were not decreased after therapy with anti-HMG-1. Together, these findings indicate that HMG-1 is a distal mediator of acute inflammatory lung injury.

Từ khóa


Tài liệu tham khảo

Repine, J. E.. 1992. Scientific perspectives on the adult respiratory distress syndrome. Lancet 339: 466

Kollef, M. H., D. P. Schuster. 1995. The acute respiratory distress syndrome. N. Engl. J. Med. 332: 27

Repine, J. E., E. Abraham. 1996. Challenges in treating ARDS. Curr. Opin. Crit. Care. 2: 73

Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. LeGall, A. M. Morris, R. Spragg. 1994. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149: 818

Hudson, L. D., J. A. Milberg, D. Anardi, R. J. Maunder. 1995. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151: 293

Abraham, E., S. Bursten, R. Shenkar, J. Allbee, R. Tuder, P. Woodson, D. M. Guidot, G. Rice, J. W. Singer, J. E. Repine. 1995. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J. Exp. Med. 181: 569

Maher, J. F., D. Nathans. 1996. Multivalent DNA-binding properties of the HMG-1 proteins. Proc. Natl. Acad. Sci. USA 93: 6716

Parkkinen, J., E. Raulo, J. Merenmies, R. Nolo, E. O. Kajander, M. Baumann, H. Rauvala. 1993. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides: enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J. Biol. Chem. 268: 19726

Bianchi, M. E., M. Beltrame. 1998. Flexing DNA: HMG-box proteins and their partners. Am. J. Hum. Genet. 63: 1573

Jayaraman, L., N. C. Moorthy, K. G. Murthy, J. L. Manley, M. Bustin, C. Prives. 1998. High mobility group protein-1 (HMG-1) is a unique activator of p53. Gene. Dev. 12: 462

Himes, S. R., R. Reeves, J. Attema, M. Nissen, Y. Li, M. F. Shannon. 2000. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J. Immunol. 164: 3157

Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, et al 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752

Parkkinen, J., H. Rauvala. 1991. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin: enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J. Biol. Chem. 266: 16730

Schmidt, A. M., S. D. Yan, J. L. Wautier, D. Stern. 1999. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in daibetic vasculopathy and atherosclerosis. Circ. Res. 84: 489

Wang, H., O. Bloom, M. Zhang, M. Ombrellino, J. Che, J. M. Vishnubhakat, A. Frazier, S. Ivanova, L. Borovikova, K. Manogue, et al 1999. Identification of HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248

Parsey, M. V., R. Tuder, E. Abraham. 1998. Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. J. Immunol. 160: 1007

Ulich, T. R., E. S. Yi, S. Yin, C. Smith, D. Remick. 1994. Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin. Immunol. Immunopathol. 72: 137

Wang, H., J. M. Vishnubhakat, O. Bloom, M. Zhang, M. Ombrellino, A. Sama, K. J. Tracey. 1999. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126: 389

Pugin, J., B. Ricou, K. P. Steinberg, P. M. Suter, T. R. Martin. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 153: 1850

Chollet-Martin, S., B. Jourdain, C. Gibert, C. Elbim, J. Chastre, M. A. Gougerot-Pocidalo. 1996. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am. J. Respir. Crit. Care Med. 154: 594

Goodman, R. B., R. M. Streiter, D. P. Martin, K. P. Steinberg, J. A. Milberg, R. J. Maunder, S. L. Kunkel, A. Walz, L. D. Hudson, T. R. Martin. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154: 602

Schmal, H., T. P. Shanley, M. L. Jones, H. P. Friedl, P. A. Ward. 1996. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 156: 1963

Gupta, S., L. Feng, T. Yoshimura, J. Redick, S. M. Fu, C. E. Rose. 1996. Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am. J. Respir. Cell Mol. Biol. 15: 656

Koh, Y., B. M. Hybertson, E. K. Jepson, J. E. Repine. 1996. Tumor necrosis factor induced acute lung leak in rats: less than with interleukin-1. Inflammation 20: 461

Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643